title: Is inhaled nitric oxide therapy more effective or safer than the conventional treatment for the treatment of vaso-occlusive crises in sickle-cell anemia?
authors.affiliation: Faculdade de Medicina de Santos UNILUS, Santos, SP, Brazil.
authors.forename: Fabio Tanzillo
authors.initials: FT
authors.lastname: Moreira
authors.forename: Camila Barbosa
authors.initials: CB
authors.lastname: de Oliveira
authors.forename: Camila Martin
authors.initials: CM
authors.lastname: Gomez
authors.forename: Wanderley Marques
authors.initials: WM
authors.lastname: Bernardo
mesh_terms: D000280:Administration, Inhalation; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000503:physiopathology; D003251:Constriction, Pathologic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000009:adverse effects; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D014665:Vasodilator Agents; D009569:Nitric Oxide